Prevalence and Associated Factors for Depression Among Patients With Sarcoma.

ABSTRACT:

Purpose

Prevalence and risk factors for depression among patients with sarcoma and survivors of sarcoma are not well characterized.

Methods

A sarcoma survivorship cohort was constructed from patients diagnosed between April 2022 and September 2023. Depression symptoms were assessed via the eight-item Patient-Reported Outcomes Measurement Information System-57 depression scale at enrollment. Standardized T-score levels (<50, 50-59, and ≥60) were calculated and evaluated in association with demographics, lifestyle characteristics, clinical data, and modifiable factors using multinomial logistic regression models.

Results

Among 612 participants, the mean T-score was 48.3 (standard deviation, 10.0); 58.8% had a T-score <50, 27.9% scored between 50 and

SUBMITTER: Robinson MJ 

PROVIDER: S-EPMC12353351 | biostudies-literature | 2025 Mar

REPOSITORIES: biostudies-literature